Navigation Links
MO BIO Laboratories, Inc. Launches the PowerWater® Sterivex™ DNA Isolation Kit
Date:5/23/2011

CARLSBAD, Calif., May 23, 2011 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of an innovative new product, the PowerWater® Sterivex™ DNA Isolation Kit.

The PowerWater® Sterivex™ DNA Isolation Kit is the only kit available to isolate genomic DNA from Millipore's Sterivex™ filter units without the need for enzymes or hazardous organic chemicals. Utilizing a novel Cell Release Solution, microbes are released from the Sterivex™ filter units without extensive incubation times or cutting open the plastic casing holding the membrane, enabling purification of high quality DNA in just 40 minutes. Patented Inhibitor Removal Technology® (IRT) is included to provide inhibitor-free DNA from all types of water samples, even those containing heavy amounts of contaminants. Isolated DNA is ready to use in downstream applications including PCR and qPCR.

The PowerWater® Sterivex™ DNA Isolation Kitis available now. For more information visit the MO BIO website (www.mobio.com/water-dna-isolation/powerwater-sterivex-dna-isolation-kit.html) or call 800-606-6246 to order.

MO BIO Laboratories, Inc. (www.mobio.com) has developed innovative tools for researchers in Molecular Biology since 1993. A global leader in solutions for soil and microbial nucleic acid purification, MO BIO's Power® kits contain patented Inhibitor Removal Technology® for removal of PCR inhibiting substances during the nucleic acid purification procedure. For samples that do not require inhibitor removal, MO BIO's UltraClean® line includes optimized products for DNA and RNA isolation from a variety of sample types. For clinical samples, the BiOstic™ kits provide solutions for higher yields and purity of nucleic acids. At MO BIO Laboratories, Inc., our focus is quality products that work, save time and function for all sample types, not just the easy ones. It is MO BIO's aim to make researchers' working lives more productive and efficient, creating time to focus on what is critical, not just in work, but in life.


'/>"/>
SOURCE MO BIO Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
2. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
3. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
4. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
5. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
6. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. Provide an Update on the Aclidinium Bromide Clinical Development Program
7. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
8. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
9. MO BIO Laboratories, Inc. Launches LifeGuard(TM) Soil Preservation Solution
10. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
11. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
(Date:5/24/2016)... 2016  NxStage Medical, Inc. (Nasdaq: NXTM ... renal care, today announced that Jeffrey H. Burbank ... following schedule of investor conferences. Where applicable, a webcast ... http://ir.nxstage.com/ .   ... NY           Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... The innovator of COMBO ... s first dual therapy stent, introduces catheters for ... OrbusNeich, a global company specializing in the provision of ... products to treat peripheral artery disease. The JADE™ and ... for lower limb and arteriovenous (AV) fistula intervention. ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... ... Stern Environmental Group , of Secaucus, New Jersey, working in conjunction ... Real Time Monitoring (RTM) Device. Stern Environmental Group will sell the first monitoring ... use in dormitories, shelters, and nursing homes for real time bedbug monitoring in May ...
(Date:5/24/2016)... ... 2016 , ... Sterling Global Products is launching a Kickstarter campaign focused on ... dispenser. The campaign kick-off video is located via this link https://youtu.be/WsO4qz2odco . The ... is to raise $1,000 per day for a total of $25,000. The funds will ...
(Date:5/24/2016)... ... May 24, 2016 , ... To better understand the impact of lung cancer ... gender differences in lung cancer. Today, the Lung Association announced Sharad Goyal, MD , ... Award, funded by the American Lung Association’s LUNG FORCE initiative, which raises awareness of ...
(Date:5/24/2016)... ... May 24, 2016 , ... i2i, ... identity and website at its “Transforming Outcomes” User Conference in Las Vegas on ... i2i’s ongoing success to set the market standard for meaningful population health management. ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... enabled solutions and managed services today announced a strategic partnership with Five9 ... center market. , Altura, one of Avaya’s largest Platinum Business Partners, is ...
Breaking Medicine News(10 mins):